Investigating the effect of Fenofibrate on biomarkers of vascular inflammation in L-NAME induced hypertensive rats

被引：0

作者：

Berzinji, Begard ^{[1
]}

Dizaye, Kawa ^{[1
]}

机构：

[1] Hawler Med Univ, Erbil, Iraq

来源：

PHARMACIA | 2022年 / 69卷 / 02期

关键词：

Fenofibrate; hypertension; inflammatory biomarkers; TYPE-2; DIABETES-MELLITUS; NITRIC-OXIDE SYNTHASE; PHOSPHOLIPASE-A2; LP-PLA2; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; CD40/CD40; LIGAND; KIDNEY-FUNCTION; RISK; MARKERS; TRIGLYCERIDES;

D O I：

10.3897/pharmacia.69.e81078

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

This study aims to evaluate the impact of fenofibrate on the levels of (IL-6, hsCRP, Lp-PLA2, sCD40L, and cystatin C) in hypertensive rats. Twenty-four rats were divided into two groups each of twelve. The first group served as the normotensive group, while the second group was regarded as the hypertensive group. Each group was further divided into two subgroups (control and treated). The control subgroups only received a placebo and the treated subgroups were given fenofibrate 30 mg/kg daily orally by gastric gavage for 4 weeks. The level of hsCRP, IL6, and Lp-PLA2 significantly increased, but sCD40L and cystatin C levels were not changed in hypertensive rats. Fenofibrate has significantly reduced the levels of hsCRP and Lp-LPA2 in hypertensive rats while IL6 and sCD40s have not been changed in both groups. In conclusion, Fenofibrate has revealed a pleiotropic anti-inflammatory effect by reducing the level of hsCRP and Lp-LPA2 in hypertensive rats.

引用

页码：459 / 465

页数：7

共 50 条

[1] Effect of chrysin endothelial vasodilation on L-NAME induced hypertensive rats
Ramanathan, Veerappan
Anandu, Dominic Amalraj Arul
Malarvili, T.
INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2020, 57 (05): : 572 - 577
[2] EFFECT OF LEVOSIMENDAN, A CALCIUM SENSITIZER, ON RENAL HEMODYNAMICS IN L-NAME INDUCED HYPERTENSIVE RATS
Abdelrahman, A.
Suleimani, Y.
Ashique, M.
Manoj, P.
Saidi, H. A.
Ali, B.
JOURNAL OF HYPERTENSION, 2019, 37 : E101 - E101
[3] β-sitosterol on heart rate variability in L-NAME induced hypertensive rats
Patel, Sanakousar
Aithala, Manjunatha
Patil, Sumangala
Das, Kusal K.
JOURNAL OF KRISHNA INSTITUTE OF MEDICAL SCIENCES UNIVERSITY, 2023, 12 (01) : 97 - 106
[4] Sympathetic activity is not increased in L-NAME hypertensive rats
dos Santos, Fernanda Machado
Martins Dias, Daniel Penteado
Aguiar da Silva, Carlos Alberto
Fazan, Rubens, Jr.
Salgado, Helio Cesar
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2010, 298 (01) : R89 - R95
[5] Beneficial Effects of Different Flavonoids on Vascular and Renal Function in L-NAME Hypertensive Rats
Dolores Paredes, M.
Romecin, Paola
Atucha, Noemi M.
O'Valle, Francisco
Castillo, Julian
Clara Ortiz, M.
Garcia-Estan, Joaquin
NUTRIENTS, 2018, 10 (04)
[6] Effect of pioglitazone on L-NAME induced hypertension in diabetic rats
Majithiya, JB
Parmar, AN
Trivedi, CJ
Balaraman, R
VASCULAR PHARMACOLOGY, 2005, 43 (04) : 260 - 266
[7] EFFECT OF LOW DOSE L-NAME PRETREATMENT ON NITRIC OXIDE/REACTIVE OXYGEN SPECIES BALANCE AND VASOACTIVITY IN L-NAME/SALT-INDUCED HYPERTENSIVE RATS
Vrankova, S.
Zemancikova, A.
Torok, J.
Pechanova, O.
JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2019, 70 (04): : 535 - 544
[8] ANTIHYPERTENSIVE AND ANTIHYPERLIPIDEMIC ACTIVITIES OF THYMOQUINONE IN L-NAME HYPERTENSIVE RATS
Azzubaidi, Marwan S.
Noor, Noriah M.
Mizher, Hussam A.
JOURNAL OF HYPERTENSION, 2015, 33 : E7 - E8
[9] Preglomerular sudanophilia in L-NAME hypertensive rats - Involvement of endothelin
Bouriquet, N
Dupont, M
Herizi, A
Mimran, A
Casellas, D
HYPERTENSION, 1996, 27 (03) : 382 - 391
[10] Effect of Oxytocin on L-NAME Induced Hypertension and Chronic Stress in Rats
Yildirim, Alper
Vatan, Merve
Dursun, Esra
Aykan, Merve
Yurtcan, Hilal
Arpaci, Dilara
Buzcu, Hulya
Cumbul, Alev
Uslu, Unal
ACTA PHYSIOLOGICA, 2015, 215 : 23 - 23

← 1 2 3 4 5 →